| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 NSD1 ISL2 ISL1 ZNF354B ZNF263 ZNF610 AGO1 ZNF792 GLI1 ZNF483 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 SUZ12 ZNF30 ZNF681 ZNF287 VDR | 4.79e-07 | 1271 | 146 | 27 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 NSD1 ISL1 ZNF354B ZNF263 ZNF610 AGO1 ZNF792 GLI1 ZNF483 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 SUZ12 ZNF30 ZNF681 ZNF287 VDR | 1.10e-06 | 1244 | 146 | 26 | GO:0000978 |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 2.38e-06 | 53 | 146 | 6 | GO:0030331 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 NSD1 ISL1 ZNF354B ZNF77 ZNF263 ZNF610 AGO1 ZNF792 GLI1 ZNF483 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 SUZ12 ZNF30 ZNF681 ZNF287 VDR | 6.56e-06 | 1459 | 146 | 27 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ABHD2 ISL2 ISL1 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 GLI1 ZNF483 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 ZNF30 ZNF681 ZNF287 VDR | 3.20e-05 | 1412 | 146 | 25 | GO:0000981 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 7.14e-05 | 187 | 146 | 8 | GO:0016922 | |
| Domain | zf-C2H2 | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 ZNF592 GLI1 ZNF483 PRDM12 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 ZNF30 ZNF681 ZNF287 | 1.90e-11 | 693 | 144 | 26 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 ZNF592 GLI1 ZNF483 PRDM12 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 SUZ12 ZNF30 ZNF681 ZNF287 | 3.98e-11 | 775 | 144 | 27 | PS50157 |
| Domain | KRAB | ZNF586 ZNF211 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 ZNF483 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 ZNF30 ZNF681 ZNF287 | 3.99e-11 | 358 | 144 | 19 | PS50805 |
| Domain | KRAB | ZNF586 ZNF211 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 ZNF483 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 ZNF30 ZNF681 ZNF287 | 3.99e-11 | 358 | 144 | 19 | PF01352 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 ZNF592 GLI1 ZNF483 PRDM12 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 SUZ12 ZNF30 ZNF681 ZNF287 | 4.22e-11 | 777 | 144 | 27 | PS00028 |
| Domain | KRAB | ZNF586 ZNF211 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 ZNF483 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 ZNF30 ZNF681 ZNF287 | 6.70e-11 | 369 | 144 | 19 | SM00349 |
| Domain | KRAB | ZNF586 ZNF211 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 ZNF483 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 ZNF30 ZNF681 ZNF287 | 7.02e-11 | 370 | 144 | 19 | IPR001909 |
| Domain | Znf_C2H2-like | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 ZNF592 GLI1 ZNF483 PRDM12 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 SUZ12 ZNF30 ZNF681 ZNF287 | 7.27e-11 | 796 | 144 | 27 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 ZNF592 GLI1 ZNF483 PRDM12 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 SUZ12 ZNF30 ZNF681 ZNF287 | 1.02e-10 | 808 | 144 | 27 | SM00355 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 GLI1 ZNF483 PRDM12 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 ZNF30 ZNF681 ZNF287 | 1.16e-10 | 694 | 144 | 25 | IPR013087 |
| Domain | - | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 GLI1 ZNF483 PRDM12 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 ZNF30 ZNF681 | 4.18e-10 | 679 | 144 | 24 | 3.30.160.60 |
| Domain | Znf_C2H2 | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 ZNF592 GLI1 ZNF483 PRDM12 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 ZNF30 ZNF681 ZNF287 | 4.93e-10 | 805 | 144 | 26 | IPR007087 |
| Domain | zf-C2H2_6 | ZNF384 ZNF586 ZNF211 ZNF366 ZNF354B ZNF77 ZNF792 ZNF483 ZNF480 ZNF616 ZNF766 ZNF420 ZNF30 ZNF681 | 1.49e-07 | 314 | 144 | 14 | PF13912 |
| Domain | Clathrin_H-chain_propeller_rpt | 5.90e-05 | 2 | 144 | 2 | IPR022365 | |
| Domain | Clathrin-link | 5.90e-05 | 2 | 144 | 2 | PF09268 | |
| Domain | - | 5.90e-05 | 2 | 144 | 2 | 2.130.10.110 | |
| Domain | Clathrin_heavy_chain | 5.90e-05 | 2 | 144 | 2 | IPR016341 | |
| Domain | MeTrfase_trithorax | 5.90e-05 | 2 | 144 | 2 | IPR016569 | |
| Domain | Clathrin_H-chain_propeller_N | 5.90e-05 | 2 | 144 | 2 | IPR001473 | |
| Domain | DUF5050 | 5.90e-05 | 2 | 144 | 2 | IPR032485 | |
| Domain | Clathrin_H-chain_link/propller | 5.90e-05 | 2 | 144 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 5.90e-05 | 2 | 144 | 2 | PF01394 | |
| Domain | Clathrin_H-chain_linker_core | 5.90e-05 | 2 | 144 | 2 | IPR015348 | |
| Domain | DUF5050 | 5.90e-05 | 2 | 144 | 2 | PF16472 | |
| Domain | ZF_CXXC | 7.08e-05 | 11 | 144 | 3 | PS51058 | |
| Domain | Znf_CXXC | 7.08e-05 | 11 | 144 | 3 | IPR002857 | |
| Domain | zf-CXXC | 7.08e-05 | 11 | 144 | 3 | PF02008 | |
| Domain | Clathrin_H-chain_linker | 1.76e-04 | 3 | 144 | 2 | IPR012331 | |
| Domain | CLH | 1.76e-04 | 3 | 144 | 2 | SM00299 | |
| Domain | Post-SET_dom | 2.34e-04 | 16 | 144 | 3 | IPR003616 | |
| Domain | PostSET | 2.34e-04 | 16 | 144 | 3 | SM00508 | |
| Domain | POST_SET | 2.34e-04 | 16 | 144 | 3 | PS50868 | |
| Domain | SET | 4.30e-04 | 46 | 144 | 4 | SM00317 | |
| Domain | FYrich_C | 5.81e-04 | 5 | 144 | 2 | IPR003889 | |
| Domain | FYrich_N | 5.81e-04 | 5 | 144 | 2 | IPR003888 | |
| Domain | FYRC | 5.81e-04 | 5 | 144 | 2 | SM00542 | |
| Domain | FYRN | 5.81e-04 | 5 | 144 | 2 | SM00541 | |
| Domain | BAAT_C | 5.81e-04 | 5 | 144 | 2 | IPR014940 | |
| Domain | ICAM_N | 5.81e-04 | 5 | 144 | 2 | PF03921 | |
| Domain | ICAM_N | 5.81e-04 | 5 | 144 | 2 | IPR013768 | |
| Domain | FYRN | 5.81e-04 | 5 | 144 | 2 | PF05964 | |
| Domain | FYRC | 5.81e-04 | 5 | 144 | 2 | PF05965 | |
| Domain | FYRC | 5.81e-04 | 5 | 144 | 2 | PS51543 | |
| Domain | FYRN | 5.81e-04 | 5 | 144 | 2 | PS51542 | |
| Domain | BAAT_C | 5.81e-04 | 5 | 144 | 2 | PF08840 | |
| Domain | SET_dom | 5.93e-04 | 50 | 144 | 4 | IPR001214 | |
| Domain | SET | 5.93e-04 | 50 | 144 | 4 | PS50280 | |
| Domain | - | RNF32 TRAF5 RNF168 KMT2B NSD1 BARD1 UBOX5 PHF3 KMT2A FGD6 RNF208 | 7.30e-04 | 449 | 144 | 11 | 3.30.40.10 |
| Domain | ICAM_VCAM_N | 8.68e-04 | 6 | 144 | 2 | IPR003987 | |
| Domain | Znf_RING/FYVE/PHD | RNF32 TRAF5 RNF168 KMT2B NSD1 BARD1 UBOX5 PHF3 KMT2A FGD6 RNF208 | 8.74e-04 | 459 | 144 | 11 | IPR013083 |
| Domain | - | 9.12e-04 | 56 | 144 | 4 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 9.75e-04 | 57 | 144 | 4 | IPR023753 | |
| Domain | cEGF | 1.02e-03 | 26 | 144 | 3 | PF12662 | |
| Domain | cEGF | 1.02e-03 | 26 | 144 | 3 | IPR026823 | |
| Domain | Clathrin | 1.21e-03 | 7 | 144 | 2 | PF00637 | |
| Domain | CHCR | 1.21e-03 | 7 | 144 | 2 | PS50236 | |
| Domain | Clathrin_H-chain/VPS_repeat | 1.60e-03 | 8 | 144 | 2 | IPR000547 | |
| Domain | zf-C2H2_11 | 2.05e-03 | 9 | 144 | 2 | PF16622 | |
| Domain | - | 2.30e-03 | 119 | 144 | 5 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 2.30e-03 | 119 | 144 | 5 | IPR029058 | |
| Domain | PHD | 2.70e-03 | 75 | 144 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 3.25e-03 | 79 | 144 | 4 | IPR019787 | |
| Domain | Quinoprot_gluc/sorb_DH | 3.70e-03 | 12 | 144 | 2 | IPR011041 | |
| Domain | SET | 3.86e-03 | 41 | 144 | 3 | PF00856 | |
| Domain | PHD | 4.99e-03 | 89 | 144 | 4 | SM00249 | |
| Domain | Ldl_recept_b | 5.06e-03 | 14 | 144 | 2 | PF00058 | |
| Domain | LDLRB | 5.06e-03 | 14 | 144 | 2 | PS51120 | |
| Domain | Znf_PHD | 5.39e-03 | 91 | 144 | 4 | IPR001965 | |
| Domain | Znf_FYVE_PHD | 5.66e-03 | 147 | 144 | 5 | IPR011011 | |
| Domain | LY | 5.80e-03 | 15 | 144 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.80e-03 | 15 | 144 | 2 | IPR000033 | |
| Domain | ZF_PHD_2 | 6.27e-03 | 95 | 144 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 6.51e-03 | 96 | 144 | 4 | PS01359 | |
| Pubmed | DCAF1 WDR7 MARK3 IGDCC4 FOCAD KLHL29 PHF3 CLTC NAV3 SUZ12 KIF17 ARHGAP21 SENP7 | 2.34e-08 | 407 | 148 | 13 | 12693553 | |
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 6.45e-08 | 49 | 148 | 6 | 9630514 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF384 RNF168 KMT2B NSD1 BARD1 DMAP1 ZNF592 PHF3 ZNF483 KMT2A SUZ12 SENP7 DNMT1 HELLS | 3.69e-07 | 608 | 148 | 14 | 36089195 |
| Pubmed | DLGAP1 DCHS2 SPTBN1 ACOT1 ARMCX4 LRP1B TF DMAP1 TMEFF1 FOCAD JAK1 DGLUCY CS ADAMTS9 ZNF592 CLTC NAV3 LRP1 ARHGAP21 DNMT1 | 5.92e-07 | 1285 | 148 | 20 | 35914814 | |
| Pubmed | 1.45e-06 | 20 | 148 | 4 | 28379358 | ||
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 11857637 | ||
| Pubmed | Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta. | 1.50e-06 | 6 | 148 | 3 | 18813964 | |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 18084289 | ||
| Pubmed | 3.72e-06 | 25 | 148 | 4 | 19304889 | ||
| Pubmed | ZBTB6 RHBDF1 ABHD2 SPTBN1 SUN1 TTC14 NSD1 UBOX5 TMEFF1 EML5 GLI1 CLTC PEAK1 PAN3 MTO1 CNOT1 ARHGAP21 | 4.01e-06 | 1084 | 148 | 17 | 11544199 | |
| Pubmed | Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. | 6.23e-06 | 9 | 148 | 3 | 10725236 | |
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 18830404 | ||
| Pubmed | Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. | 6.23e-06 | 9 | 148 | 3 | 12361967 | |
| Pubmed | Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP. | 7.92e-06 | 30 | 148 | 4 | 22963397 | |
| Pubmed | 8.12e-06 | 64 | 148 | 5 | 19729601 | ||
| Pubmed | Differential requirement for Gli2 and Gli3 in ventral neural cell fate specification. | 8.87e-06 | 10 | 148 | 3 | 12812795 | |
| Pubmed | 8.87e-06 | 10 | 148 | 3 | 11748151 | ||
| Pubmed | Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. | 8.87e-06 | 10 | 148 | 3 | 11395002 | |
| Pubmed | 8.87e-06 | 10 | 148 | 3 | 16928730 | ||
| Pubmed | 8.87e-06 | 10 | 148 | 3 | 20569692 | ||
| Pubmed | 1.22e-05 | 11 | 148 | 3 | 11988168 | ||
| Pubmed | 1.32e-05 | 34 | 148 | 4 | 25631876 | ||
| Pubmed | 1.33e-05 | 181 | 148 | 7 | 37372979 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 20150232 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 28530676 | ||
| Pubmed | Association between genetic polymorphisms of ACE & eNOS and diabetic nephropathy. | 1.80e-05 | 2 | 148 | 2 | 25227524 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.80e-05 | 2 | 148 | 2 | 15963947 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27089712 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 33673789 | ||
| Pubmed | ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. | 1.80e-05 | 2 | 148 | 2 | 15498534 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21844127 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11821712 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24505959 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 26670794 | ||
| Pubmed | eNOS gene Glu298Asp variant confer risk in sudden sensorineural hearing loss. | 1.80e-05 | 2 | 148 | 2 | 30354859 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12687832 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15724677 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 7721852 | ||
| Pubmed | Genetic susceptibility to atrial fibrillation in patients with congestive heart failure. | 1.80e-05 | 2 | 148 | 2 | 16818212 | |
| Pubmed | Genetic predisposition to breath-hold diving-induced hemoptysis: Preliminary study. | 1.80e-05 | 2 | 148 | 2 | 26094307 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18269824 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18629615 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21919778 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11361058 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11485372 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12015245 | ||
| Pubmed | eNOS and ACE genes influence peripheral arterial disease predisposition in smokers. | 1.80e-05 | 2 | 148 | 2 | 20478683 | |
| Pubmed | ACE I/D and eNOS E298D gene polymorphisms in Saudi subjects with hypertension. | 1.80e-05 | 2 | 148 | 2 | 23042814 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20540812 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16213264 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11522715 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 14989558 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 7822326 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15115168 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23867713 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11030378 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27328622 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 17563560 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31437068 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23011259 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12837457 | ||
| Pubmed | Aspects of the molecular-genetic profile in patients with ischemic heart disease. | 1.80e-05 | 2 | 148 | 2 | 24505896 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21383065 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23603420 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 8733129 | ||
| Pubmed | KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. | 1.80e-05 | 2 | 148 | 2 | 28723559 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22695028 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22895845 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21747292 | ||
| Pubmed | LDL-receptor-related protein regulates beta2-integrin-mediated leukocyte adhesion. | 1.80e-05 | 2 | 148 | 2 | 15328156 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19255721 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 29097553 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24827774 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15292102 | ||
| Pubmed | The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step. | 1.80e-05 | 2 | 148 | 2 | 20065094 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16915032 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15338496 | ||
| Pubmed | Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. | 1.80e-05 | 2 | 148 | 2 | 24284821 | |
| Pubmed | 2.09e-05 | 13 | 148 | 3 | 38509075 | ||
| Pubmed | Diminished Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice. | 2.09e-05 | 13 | 148 | 3 | 9636069 | |
| Pubmed | 2.42e-05 | 80 | 148 | 5 | 19420105 | ||
| Pubmed | A hypomorphic allele reveals an important role of inturned in mouse skeletal development. | 2.66e-05 | 14 | 148 | 3 | 25774014 | |
| Pubmed | 2.66e-05 | 14 | 148 | 3 | 21674568 | ||
| Pubmed | 2.66e-05 | 14 | 148 | 3 | 29962937 | ||
| Pubmed | PUS3 COPG1 WDR7 ARFGEF1 PKHD1L1 BTBD3 PI4KB CLTC ADAMTS16 PEAK1 ARHGAP21 DNMT1 HELLS | 3.01e-05 | 777 | 148 | 13 | 35844135 | |
| Pubmed | 3.31e-05 | 15 | 148 | 3 | 11436125 | ||
| Pubmed | 3.41e-05 | 43 | 148 | 4 | 20565774 | ||
| Pubmed | PARP14 DMAP1 ZNF592 PRDM12 KMT2A SUZ12 CNOT1 DNMT1 VDR HELLS | 3.51e-05 | 469 | 148 | 10 | 27634302 | |
| Pubmed | 3.74e-05 | 44 | 148 | 4 | 24183668 | ||
| Pubmed | 4.06e-05 | 16 | 148 | 3 | 28800946 | ||
| Pubmed | Gli2 and Gli3 play distinct roles in the dorsoventral patterning of the mouse hindbrain. | 4.06e-05 | 16 | 148 | 3 | 17026983 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CLTCL1 COPG1 SPTBN1 DAPK1 ACE DDX5 CS PPA2 CLTC KMT2A PEAK1 MYO15A CNOT1 | 4.43e-05 | 807 | 148 | 13 | 30575818 |
| Pubmed | Genome-wide association analysis of age-at-onset in Alzheimer's disease. | 4.91e-05 | 17 | 148 | 3 | 22005931 | |
| Pubmed | 4.91e-05 | 17 | 148 | 3 | 20413850 | ||
| Pubmed | Lp(a) and risk of recurrent cardiac events in obese postinfarction patients. | 4.91e-05 | 17 | 148 | 3 | 18927546 | |
| Pubmed | Differential Islet-1 expression among lumbosacral spinal motor neurons in prenatal mouse. | 5.38e-05 | 3 | 148 | 2 | 19236857 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 25181428 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 24452940 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 24435163 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 16263504 | ||
| Interaction | LCOR interactions | 1.47e-06 | 242 | 145 | 11 | int:LCOR | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF134 ZNF586 ZNF211 KMT2B PSG11 ZNF233 ZNF230 POLR1G ZNF610 ZNF792 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 ZNF30 | 3.45e-07 | 1192 | 148 | 17 | chr19q13 |
| Cytoband | 19q13.41 | 5.68e-06 | 78 | 148 | 5 | 19q13.41 | |
| Cytoband | 3q21.1 | 3.59e-05 | 20 | 148 | 3 | 3q21.1 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF384 ZNF134 ZBTB6 ZNF586 ZNF211 ZNF366 ZNF233 ZNF230 ZNF354B ZNF77 ZNF263 ZNF610 ZNF792 ZNF592 GLI1 ZNF483 PRDM12 ZNF534 ZNF480 ZNF616 ZNF766 ZNF420 ZNF470 SUZ12 ZNF30 ZNF681 ZNF287 | 1.18e-14 | 718 | 109 | 27 | 28 |
| GeneFamily | Zinc fingers CXXC-type | 4.51e-05 | 12 | 109 | 3 | 136 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.11e-03 | 34 | 109 | 3 | 487 | |
| GeneFamily | Acyl-CoA thioesterases | 1.57e-03 | 10 | 109 | 2 | 41 | |
| GeneFamily | PHD finger proteins | 2.15e-03 | 90 | 109 | 4 | 88 | |
| GeneFamily | LIM class homeoboxes | 2.28e-03 | 12 | 109 | 2 | 522 | |
| GeneFamily | Low density lipoprotein receptors | 2.69e-03 | 13 | 109 | 2 | 634 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.94e-06 | 174 | 148 | 7 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.09e-06 | 176 | 148 | 7 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-06 | 185 | 148 | 7 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-06 | 185 | 148 | 7 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 192 | 148 | 7 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 192 | 148 | 7 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 192 | 148 | 7 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 194 | 148 | 7 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.55e-06 | 198 | 148 | 7 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 4.86e-06 | 200 | 148 | 7 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.03e-05 | 148 | 148 | 6 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.03e-05 | 148 | 148 | 6 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-05 | 163 | 148 | 6 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-05 | 163 | 148 | 6 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 165 | 148 | 6 | 50f1fa7434ebb777e15d5273d1ff41070cff6db3 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 167 | 148 | 6 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 167 | 148 | 6 | b94e8ee8c3fcebedd8fcd719eadddc04c7513c50 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-05 | 170 | 148 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.41e-05 | 172 | 148 | 6 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 172 | 148 | 6 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.57e-05 | 174 | 148 | 6 | d77fa525d5c87c190b4a10787b270eabd16c610f | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-05 | 180 | 148 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 182 | 148 | 6 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 184 | 148 | 6 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.51e-05 | 184 | 148 | 6 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.62e-05 | 185 | 148 | 6 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.73e-05 | 186 | 148 | 6 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 186 | 148 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.73e-05 | 186 | 148 | 6 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.84e-05 | 187 | 148 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-05 | 187 | 148 | 6 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-05 | 188 | 148 | 6 | 5d166d9e71632edd059ff0a9f66f8763f259d40a | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 188 | 148 | 6 | 921a2c9212a0f2a00fd72c594d80924f27e8b9b7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 190 | 148 | 6 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | Control-B_naive-4|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.30e-05 | 116 | 148 | 5 | 35d471c8dbf408d0be3837c428d9c2a73c805a6f | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.32e-05 | 191 | 148 | 6 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 4.32e-05 | 191 | 148 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | MS-Treg-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 4.45e-05 | 192 | 148 | 6 | c6722bf142c84ccedd99c1a3344085aecb4cbab4 | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 4.58e-05 | 193 | 148 | 6 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 193 | 148 | 6 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 193 | 148 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-05 | 194 | 148 | 6 | cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-05 | 194 | 148 | 6 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 194 | 148 | 6 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 194 | 148 | 6 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-05 | 195 | 148 | 6 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 195 | 148 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-05 | 196 | 148 | 6 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-05 | 197 | 148 | 6 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-05 | 197 | 148 | 6 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-05 | 197 | 148 | 6 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 198 | 148 | 6 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-05 | 198 | 148 | 6 | ff8a9adc1302a4679ccdfe9ef95ef53e4c7a5391 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 198 | 148 | 6 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-05 | 198 | 148 | 6 | 09e452742aed9f48bf1ffc35c6b06a296bcfe076 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-05 | 198 | 148 | 6 | 4a70a1ab40fe30b90acd97e4e36067db62acc905 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 198 | 148 | 6 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.43e-05 | 199 | 148 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Transverse-T_cell-Tfh|T_cell / Region, Cell class and subclass | 5.43e-05 | 199 | 148 | 6 | 33ffea12b8228e0b5bd8942531c3b21d24224725 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.58e-05 | 200 | 148 | 6 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.58e-05 | 200 | 148 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.48e-05 | 137 | 148 | 5 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 140 | 148 | 5 | a88dbe7bf3e1419e360ab0b8cf24681d3424c3a7 | |
| Drug | cholesteryl ether | 3.90e-07 | 24 | 146 | 5 | CID000296867 | |
| Drug | AC1OAR8J | 1.03e-06 | 4 | 146 | 3 | CID006834124 | |
| Disease | Weaver syndrome | 9.94e-07 | 5 | 138 | 3 | C0265210 | |
| Disease | lysophosphatidylethanolamine 18:1 measurement | 1.90e-05 | 34 | 138 | 4 | EFO_0010368 | |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 4.37e-05 | 15 | 138 | 3 | EFO_0010367 | |
| Disease | hepatitis (implicated_via_orthology) | 6.49e-05 | 3 | 138 | 2 | DOID:2237 (implicated_via_orthology) | |
| Disease | apolipoprotein A 1 measurement | RNF168 ETFDH NSD1 DGKG TF LIPC SLC12A3 GLI1 ZNF483 LRP1 KMT2A CNOT1 MUSK | 1.81e-04 | 848 | 138 | 13 | EFO_0004614 |
| Disease | unipolar depression, neuroticism measurement | 1.89e-04 | 24 | 138 | 3 | EFO_0003761, EFO_0007660 | |
| Disease | nephritis (is_implicated_in) | 2.15e-04 | 5 | 138 | 2 | DOID:10952 (is_implicated_in) | |
| Disease | Fabry disease (is_implicated_in) | 2.15e-04 | 5 | 138 | 2 | DOID:14499 (is_implicated_in) | |
| Disease | limb ischemia (implicated_via_orthology) | 2.15e-04 | 5 | 138 | 2 | DOID:0050852 (implicated_via_orthology) | |
| Disease | Carcinoma, Granular Cell | 2.20e-04 | 116 | 138 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.20e-04 | 116 | 138 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.20e-04 | 116 | 138 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.20e-04 | 116 | 138 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.20e-04 | 116 | 138 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 2.20e-04 | 116 | 138 | 5 | C0001418 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 3.01e-04 | 28 | 138 | 3 | DOID:8466 (biomarker_via_orthology) | |
| Disease | Respiratory Tract Diseases | 3.22e-04 | 6 | 138 | 2 | C0035242 | |
| Disease | 1-oleoyl-2-docosahexaenoyl-GPE (18:1/22:6) measurement | 3.22e-04 | 6 | 138 | 2 | EFO_0800471 | |
| Disease | 1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3) measurement | 3.22e-04 | 6 | 138 | 2 | EFO_0800444 | |
| Disease | Congenital Pain Insensitivity | 4.49e-04 | 7 | 138 | 2 | C0002768 | |
| Disease | level of Phosphatidylcholine (18:2_20:3) in blood serum | 4.49e-04 | 7 | 138 | 2 | OBA_2045108 | |
| Disease | level of Phosphatidylcholine (18:2_20:4) in blood serum | 4.49e-04 | 7 | 138 | 2 | OBA_2045109 | |
| Disease | 1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) measurement | 4.49e-04 | 7 | 138 | 2 | EFO_0800470 | |
| Disease | 1-oleoyl-2-linoleoyl-GPE (18:1/18:2) measurement | 4.49e-04 | 7 | 138 | 2 | EFO_0800443 | |
| Disease | level of Phosphatidylcholine (17:0_18:2) in blood serum | 4.49e-04 | 7 | 138 | 2 | OBA_2045086 | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 5.39e-04 | 34 | 138 | 3 | DOID:5082 (biomarker_via_orthology) | |
| Disease | 2-arachidonoyl-GPE (20:4) measurement | 5.97e-04 | 8 | 138 | 2 | EFO_0800260 | |
| Disease | bone measurement | 5.97e-04 | 8 | 138 | 2 | EFO_0004512 | |
| Disease | 1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6) measurement | 5.97e-04 | 8 | 138 | 2 | EFO_0800450 | |
| Disease | Behcet's disease (is_implicated_in) | 6.38e-04 | 36 | 138 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | 1-arachidonoyl-GPE (20:4n6) measurement | 7.65e-04 | 9 | 138 | 2 | EFO_0800248 | |
| Disease | octanoylcarnitine measurement | 7.65e-04 | 9 | 138 | 2 | EFO_0021042 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) measurement | 7.65e-04 | 9 | 138 | 2 | EFO_0800409 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) measurement | 7.65e-04 | 9 | 138 | 2 | EFO_0800403 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) measurement | 7.65e-04 | 9 | 138 | 2 | EFO_0800272 | |
| Disease | X-17653 measurement | 7.65e-04 | 9 | 138 | 2 | EFO_0800783 | |
| Disease | Carcinoma, Transitional Cell | 9.37e-04 | 41 | 138 | 3 | C0007138 | |
| Disease | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 9.53e-04 | 10 | 138 | 2 | EFO_0800608 | |
| Disease | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) measurement | 9.53e-04 | 10 | 138 | 2 | EFO_0800402 | |
| Disease | cholesteryl ester 22:5 measurement | 9.53e-04 | 10 | 138 | 2 | EFO_0021444 | |
| Disease | aspartate aminotransferase measurement | ZNF366 MARK3 SUN1 ETFDH NSD1 POLR1G TMEFF1 DGLUCY LIPC ADAMTS9 GLI1 MYO15A | 1.14e-03 | 904 | 138 | 12 | EFO_0004736 |
| Disease | Posterior Choroidal Artery Infarction | 1.16e-03 | 11 | 138 | 2 | C0887799 | |
| Disease | Cerebral Infarction, Left Hemisphere | 1.16e-03 | 11 | 138 | 2 | C0751010 | |
| Disease | Anterior Choroidal Artery Infarction | 1.16e-03 | 11 | 138 | 2 | C0751012 | |
| Disease | Cerebral Infarction, Right Hemisphere | 1.16e-03 | 11 | 138 | 2 | C0751011 | |
| Disease | Subcortical Infarction | 1.16e-03 | 11 | 138 | 2 | C0751014 | |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 1.16e-03 | 11 | 138 | 2 | EFO_0800269 | |
| Disease | Cerebral Infarction | 1.16e-03 | 11 | 138 | 2 | C0007785 | |
| Disease | smoking status measurement, forced expiratory volume | 1.16e-03 | 11 | 138 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | obstructive sleep apnea (is_implicated_in) | 1.16e-03 | 11 | 138 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | myocardial infarction (is_implicated_in) | 1.22e-03 | 99 | 138 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | coronary artery disease (is_implicated_in) | 1.27e-03 | 100 | 138 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | metabolite measurement, body weight gain | 1.39e-03 | 12 | 138 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | decanoylcarnitine measurement | 1.39e-03 | 12 | 138 | 2 | EFO_0021039 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement | 1.39e-03 | 12 | 138 | 2 | EFO_0800466 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 1.39e-03 | 12 | 138 | 2 | OBA_2045157 | |
| Disease | level of Phosphatidylcholine (16:0_20:2) in blood serum | 1.39e-03 | 12 | 138 | 2 | OBA_2045074 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 1.63e-03 | 107 | 138 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | liver cirrhosis (implicated_via_orthology) | 1.64e-03 | 13 | 138 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | methylcobalamin deficiency type cblE, response to antineoplastic agent | 1.64e-03 | 13 | 138 | 2 | GO_0097327, MONDO_0009354 | |
| Disease | hypothyroidism (implicated_via_orthology) | 1.64e-03 | 13 | 138 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 1.64e-03 | 13 | 138 | 2 | OBA_2045072 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 1.64e-03 | 13 | 138 | 2 | OBA_2045082 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.64e-03 | 13 | 138 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.65e-03 | 181 | 138 | 5 | DOID:684 (is_implicated_in) | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 1.67e-03 | 50 | 138 | 3 | EFO_0010732 | |
| Disease | diabetic retinopathy (is_implicated_in) | 1.67e-03 | 50 | 138 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | Malignant mesothelioma | 1.74e-03 | 109 | 138 | 4 | C0345967 | |
| Disease | sitting height ratio | 1.77e-03 | 51 | 138 | 3 | EFO_0007118 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 1.77e-03 | 51 | 138 | 3 | EFO_0022285 | |
| Disease | S-6-hydroxywarfarin measurement | 1.78e-03 | 368 | 138 | 7 | EFO_0803326 | |
| Disease | myocarditis (implicated_via_orthology) | 1.90e-03 | 14 | 138 | 2 | DOID:820 (implicated_via_orthology) | |
| Disease | atrial fibrillation (is_implicated_in) | 1.90e-03 | 14 | 138 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 1.90e-03 | 14 | 138 | 2 | OBA_2045100 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 1.90e-03 | 14 | 138 | 2 | OBA_2045142 | |
| Disease | lysophosphatidylcholine 15:0 measurement | 1.90e-03 | 14 | 138 | 2 | EFO_0020941 | |
| Disease | anemia (is_implicated_in) | 1.90e-03 | 14 | 138 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 2.19e-03 | 15 | 138 | 2 | OBA_2045131 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 2.19e-03 | 15 | 138 | 2 | OBA_2045067 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.20e-03 | 55 | 138 | 3 | C0079744 | |
| Disease | HOMA-B | 2.20e-03 | 55 | 138 | 3 | EFO_0004469 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 2.20e-03 | 55 | 138 | 3 | EFO_0022288 | |
| Disease | ovarian cancer (is_implicated_in) | 2.31e-03 | 56 | 138 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | peak expiratory flow | 2.44e-03 | 498 | 138 | 8 | EFO_0009718 | |
| Disease | coronary thrombosis, GM11992 | 2.50e-03 | 16 | 138 | 2 | EFO_0001124, EFO_1000883 | |
| Disease | pneumonia (is_implicated_in) | 2.50e-03 | 16 | 138 | 2 | DOID:552 (is_implicated_in) | |
| Disease | Pre-Eclampsia | 2.50e-03 | 16 | 138 | 2 | C0032914 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 2.50e-03 | 16 | 138 | 2 | OBA_2045090 | |
| Disease | Prostatic Neoplasms | 2.52e-03 | 616 | 138 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.52e-03 | 616 | 138 | 9 | C0376358 | |
| Disease | serum alanine aminotransferase measurement | DLGAP1 MARK3 COL27A1 DGLUCY LIPC ADAMTS9 P4HA1 CNOT1 MUSK SENP7 DNMT1 | 2.64e-03 | 869 | 138 | 11 | EFO_0004735 |
| Disease | free cholesterol to total lipids in medium HDL percentage | 2.82e-03 | 60 | 138 | 3 | EFO_0022282 | |
| Disease | Uremia | 2.82e-03 | 17 | 138 | 2 | C0041948 | |
| Disease | Lipidemias | 2.82e-03 | 17 | 138 | 2 | C1706412 | |
| Disease | Hyperlipidemia | 2.82e-03 | 17 | 138 | 2 | C0020473 | |
| Disease | optic disc size measurement | 2.83e-03 | 205 | 138 | 5 | EFO_0004832 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.95e-03 | 61 | 138 | 3 | DOID:3587 (is_marker_for) | |
| Disease | alkaline phosphatase measurement | ZNF366 SPTBN1 JAK1 KIF9 LIPC CELA3A KIF17 CNOT1 ARHGAP21 MUSK SENP7 DNMT1 | 2.97e-03 | 1015 | 138 | 12 | EFO_0004533 |
| Disease | syndrome (implicated_via_orthology) | 3.16e-03 | 18 | 138 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | essential hypertension (is_implicated_in) | 3.16e-03 | 18 | 138 | 2 | DOID:10825 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PFNGDCRITKDNRRH | 61 | P11473 | |
| RLQAHGRRKPQIICY | 341 | Q86TX2 | |
| CNLDISNKYGRTPLH | 601 | P53355 | |
| NSSQRRYTGKVPCNH | 796 | Q8NHU2 | |
| ELQRICYNTKPGASR | 36 | Q8N336 | |
| DLCNYHPERVRQGKV | 741 | Q99728 | |
| RGAQYQPILRDHICK | 1401 | P26358 | |
| EGPLHQCDIYRSTKA | 551 | P12821 | |
| GRYRPQECKALQRVA | 111 | O60513 | |
| CPGIANHSEKQYIRT | 131 | P08910 | |
| LIRHCAKYVSDRPQA | 1346 | Q9Y6D6 | |
| KYRVCNVTRRPASHQ | 276 | Q9UL18 | |
| RLQAHGKERPQIICY | 341 | Q3I5F7 | |
| ARKGLVPQRCHRFQS | 366 | Q9Y2F9 | |
| PRRHYTSQQELKDEC | 71 | O14490 | |
| HRGFPLIKTRDICNQ | 401 | Q5JTW2 | |
| HPDGNRKLAVAYSCL | 171 | Q9GZS0 | |
| LCEHKYGNAPRVRIN | 241 | O14874 | |
| GTQACRKTQPNIHDY | 1081 | Q5H9R4 | |
| GAQSRPVQCTRRVHY | 946 | Q8TE57 | |
| HSGVYVCRANKPRTR | 306 | Q8TDY8 | |
| VYHADCLNLTKRPAG | 2141 | Q96L73 | |
| HGPICTEYAINKLRQ | 441 | P23458 | |
| NRYGDVPCLDQTRVK | 331 | P43378 | |
| PAVRTGLYCRDQAHA | 21 | Q6IWH7 | |
| NLKVRHQRTEECYLP | 371 | Q6IE37 | |
| YLREQHARCKNPVAT | 1011 | Q9Y4B6 | |
| DRCHRIGQTKPVVVY | 706 | Q9NRZ9 | |
| YHTPGSVENLRRQAC | 161 | Q5VVH5 | |
| IYQKRTQPTVRSHAC | 461 | Q9NZR2 | |
| RRINYCALNKPGCEH | 401 | O00339 | |
| QCNSFYIPRHIRKEE | 121 | O60565 | |
| NRGQHVCPLSRRAYI | 3261 | Q9UKN7 | |
| LNSHVKETTRGPRYC | 301 | Q9Y2Z2 | |
| PRVRSHACENDQYGK | 471 | Q07954 | |
| YRRSKEITVRGHNCP | 76 | P17844 | |
| QHGKSPDLYERQVCL | 1481 | Q9H792 | |
| RQNGPVIYKHRSRIC | 1776 | Q8IVL0 | |
| CNTLGYHVRQEPRSK | 321 | P11150 | |
| SQCPRLEHYGQVQVK | 801 | P08151 | |
| PHGAARAEVYLRKCT | 2506 | Q9UMN6 | |
| ALGDQKRDHIPFRQC | 281 | Q9HAQ2 | |
| YPGKVREARCQASVH | 481 | Q8NAT1 | |
| RLHTGERPYKCQVCQ | 291 | Q9H4Q4 | |
| SRYRGQEHCLHPKLQ | 76 | O95715 | |
| KTRHVLQCQARGNPY | 416 | P32942 | |
| EIGTRNLCDPHRYNI | 361 | P29474 | |
| EIQRINEHPYRKCSD | 3106 | Q6V1P9 | |
| YSTRHAACPVLVGNK | 496 | P13674 | |
| EREVKSPGARHCYQD | 231 | Q8WX93 | |
| NSKDDLPYCLRRIHG | 511 | Q58A45 | |
| YDRVTQHLCLKGPSA | 501 | Q460N5 | |
| PNDGRCHLEDNLYKR | 281 | P05107 | |
| KYTVHERCVSRNIPG | 306 | P49619 | |
| HPLYNRVKTGQIANC | 246 | Q9H461 | |
| KELYSVRNIRPSCHG | 446 | Q16134 | |
| IGTHKIARETECNPY | 1526 | Q9P2N4 | |
| YHICAKLANVRAVPG | 196 | Q9NPF5 | |
| CYQSPALEGVRKEHQ | 121 | Q8N6M3 | |
| QQARLPVVDYKHCSR | 176 | P09093 | |
| GHAVLRKTDPRYTCQ | 346 | O75390 | |
| HLRKQCGQADTYQSP | 231 | Q8IZC6 | |
| VQSVEKPQYRGTLHC | 31 | Q8N8R3 | |
| CADEQPHIGNYRLLK | 46 | P27448 | |
| IPKSEDRRYCNSHLQ | 66 | Q53TQ3 | |
| PNCYSRVINIDGQKH | 3911 | Q03164 | |
| KEDNYRGPAVRALCQ | 116 | Q9Y678 | |
| KVNLGHAARTVCYSP | 1731 | Q05BV3 | |
| GPAIRKQNLCAYHVQ | 111 | Q92904 | |
| CAVHSQYLRKAVGPS | 536 | Q7Z3D6 | |
| ITPKHNGLYACSARN | 291 | Q9UQ72 | |
| QLPDRCTLKTGHYNI | 46 | Q96IW7 | |
| CQQHRVKAPVYRTDR | 1706 | O75923 | |
| IRDICKQRPYQHGAD | 591 | Q5VW36 | |
| IDNCYHRAAEGRAPK | 161 | Q96RD6 | |
| GRKYTLRCHVTQVFP | 146 | Q14773 | |
| KQLHTLRTCYAANPR | 201 | Q96A47 | |
| ALVDGRCKHVPYRDS | 276 | Q9P2E2 | |
| AAHNKCPRDGRFVEQ | 36 | Q9Y3D3 | |
| RPRIHCNKISADGYE | 11 | O94941 | |
| NPHKSCYLSERGSQR | 216 | Q9BQF6 | |
| DRPKCQGLESRIQHF | 416 | Q9BZE2 | |
| RPQRCAQVLHVDYGR | 336 | O60522 | |
| HFALEKVYLQQRRCP | 101 | B2RXF0 | |
| AENKQLRRAGCPYQA | 396 | Q9UFD9 | |
| LANYTCHVENRNGRK | 326 | Q9NP60 | |
| IRHCSQRYGKLKPQV | 106 | Q96CC6 | |
| KRHRYRVLSSCPQAG | 76 | O15446 | |
| PLCRKNQYQTRVIHD | 166 | Q9H0A6 | |
| THQEQGRSYKEVCAP | 221 | Q9BVR0 | |
| KQLHTLRTCYAANPR | 191 | P61371 | |
| HTEERGQPCSQNYRL | 36 | Q9H2U2 | |
| TLNCQNSYVEPHKIR | 201 | Q9NZD8 | |
| GDAIKPYIVHRCRQS | 191 | Q9UBF8 | |
| HYGCAVTDKRRNLQQ | 226 | O00463 | |
| YKPCDPQVIRDRVAH | 601 | Q01082 | |
| KRDPHLACVAYERGQ | 911 | Q00610 | |
| KRDPHLACVAYERGQ | 911 | P53675 | |
| KHARQEGRRYCDPVV | 1531 | A5YKK6 | |
| AKYPEHQQRCRDEIR | 331 | Q86W10 | |
| TNHQRIHTGERPYKC | 416 | Q8N9Z0 | |
| RHYLCNRPVGSDQKA | 1231 | A0JNW5 | |
| HQKISRQKPRECQEY | 111 | P17039 | |
| KHRNVRTGERPYECS | 111 | Q9NXT0 | |
| QQHTRIHTGDRPYKC | 361 | Q8TF68 | |
| FENRQRSHTGQRPCK | 151 | Q15935 | |
| NNGCLVSPHIREKTY | 171 | Q08AN1 | |
| QHQRIHTGEKPYACR | 721 | Q9HBT7 | |
| TRKPVEEYANCHLAR | 586 | P02787 | |
| CGHSYNVTQRRPRVL | 146 | Q9H0X6 | |
| HPKGARIDVSINECY | 481 | Q15022 | |
| HGRTLKRYPCRQCEQ | 1006 | Q92610 | |
| GLDYLKNQPARVCEH | 1261 | Q6ZV73 | |
| ACYLTNHGRRIPKDV | 121 | Q9NWM0 | |
| VQHQRLHSGKRPYEC | 581 | Q6ECI4 | |
| QHRRVHTGKRPYQCS | 526 | Q13398 | |
| QHRNIHTGVKPYSCN | 636 | Q76KX8 | |
| PEYHKENRRCSRNSG | 191 | Q92576 | |
| DHIKNYRPQCLVLTG | 636 | P55017 | |
| LALENCPTHRNARKY | 366 | Q96N46 | |
| EKINGVARCPYDPRH | 221 | Q9P283 | |
| SYDRNICQKRVPLGE | 2596 | Q86WI1 | |
| PRLCQYVDISRGKHE | 51 | Q8TEA7 | |
| RCGQRAHPSNIYKVE | 191 | A1L157 | |
| ERHPGDSKNYNECIR | 231 | Q9H832 | |
| QKHYPRECKLRASGQ | 81 | Q8IYW5 | |
| TNHQRIHTGERPYKC | 471 | Q8WV37 | |
| RKPGCCRSQSLHYQE | 161 | P0C7T8 | |
| QEVTLRCKPISGHDY | 36 | A0A0B4J2E0 | |
| KRHLTTHRGPIQYNC | 381 | Q8N895 | |
| QKVTPRRYGKCEHEN | 96 | Q96N22 | |
| ECGKAFNQRPTLIRH | 566 | Q3KQV3 | |
| LHQRVHTGERPYNCK | 381 | Q9UIE0 | |
| PHQRVSTGENLYRCQ | 331 | A6NK53 | |
| RHQRIHTGEKPYLCN | 596 | Q8TF39 | |
| SRHQRIHTGEKPYQC | 631 | Q8TAQ5 | |
| RVRHYLVKCPQNSSG | 211 | Q8IW00 | |
| GPVSRVYSRDRNQKC | 206 | O94901 | |
| QEQKAHIRRKPYECN | 176 | Q5HY98 | |
| HIRRKPYECNEQGKV | 181 | Q5HY98 | |
| HQKEITVIARGPCYS | 131 | Q8IYR6 | |
| NHQRIHTGEKPYRCL | 511 | Q96LW1 | |
| PKVTFRTRIYHCNIN | 111 | P51965 | |
| CERPRQQEIHKSFRG | 541 | Q5T5U3 | |
| RGHRNKVTCLLYPHQ | 461 | Q9Y4E6 | |
| IVHQRVHNGARPYKC | 276 | P52741 | |
| CYQELLSRGQAREHP | 651 | Q9BYX2 | |
| QNLEEGYSLRHQCPR | 291 | Q15916 | |
| RHQRTHTGEKPYQCN | 451 | O14978 | |
| VPRCRHNSLVYDGKI | 671 | Q96CT2 | |
| RIHNVQKEDAGQYRC | 176 | O15146 |